// App-Quantinova.ai

1492 : Development of a CD123xCD3 bispecific antibody to treat acute myeloid leukemia (AML)

Researchers

Presenter

  • Francois Gaudet

Principal Investigators

  • Jennifer F. Nemeth

  • Ronan McDaid

  • Yingzhe Li

  • Benjamin Harman

  • Hillary Millar

  • Alexey Teplyakov

  • John Wheeler

  • Jinquan Luo

  • Susan Tam

  • Sheng-Jiun Wu

  • Emily Chen

  • Alexander Babich

  • Yusri Elsayed

  • Ricardo Attar

Medical Centers

  • Janssen, Spring House, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

  • Solid malignancies

Biomarkers

  • Peripheral blood mononuclear cell

  • Cluster of Differentiation 25

  • Cluster of Differentiation 2AP

  • Cluster of differentiation 69

Drug/Treatment

  • Interleukin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved